Patents by Inventor Steven Fauce

Steven Fauce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9913851
    Abstract: The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and for enhancing proliferation of stem and progenitor cells.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: March 13, 2018
    Assignee: TELOMERASE ACTIVATION SCIENCES, INC.
    Inventors: Calvin Bruce Harley, Soo-Peang Khor, Mahesh Ramaseshan, Premchandran H. Ramiya, Zhu Z. Pirot, Steven Fauce, Tong Lin
  • Patent number: 9403866
    Abstract: The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and for enhancing proliferation of stem and progenitor cells.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: August 2, 2016
    Assignee: TELOMERASE ACTIVATION SCIENCES, INC.
    Inventors: Calvin Bruce Harley, Soo-Peang Khor, Mahesh Ramaseshan, Premchandran H. Ramiya, Zhu Z. Pirot, Steven Fauce, Tong Lin
  • Patent number: 8481721
    Abstract: The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and for enhancing proliferation of stem and progenitor cells.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: July 9, 2013
    Assignee: Telomerase Activation Sciences, Inc.
    Inventors: Calvin B. Harley, Soo-Peang Khor, Mahesh Ramaseshan, Premchandran Ramiya, Zhu Zhen Pirot, Steven Fauce, Tong Lin
  • Publication number: 20100292197
    Abstract: The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and for enhancing proliferation of stem and progenitor cells.
    Type: Application
    Filed: May 17, 2010
    Publication date: November 18, 2010
    Inventors: Calvin B. Harley, Soo-Peang Khor, Mahesh Ramaseshan, Premchandran Ramiya, Zhu Zhen Pirot, Steven Fauce, Tong Lin